Entry Detail



General Information

Database ID:exR0763192
RNA Name:RPS27A
RNA Type:mRNA
Chromosome:chr2
Starnd:+
Coordinate:
Start Site(bp):55231903End Site(bp):55235853
External Links:ENSG00000143947



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF2
chr7
151207837
151227166
-
ABHD2
chr15
89087459
89202355
+
ABRACL
chr6
139028745
139043302
+
AC068946.1
chr2
219075329
219170827
-
AC091167.2
chr15
90249556
90272208
+
AC245033.1
chr15
82536788
82573194
-
ACAD8
chr11
134253495
134265855
+
ACLY
chr17
41866917
41930542
-
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTR2
chr2
65227753
65271253
+
ACVR1
chr2
157736444
157876330
-
ADAR
chr1
154582057
154628013
-
ADD1
chr4
2843857
2930076
+
ADORA2A
chr22
24417879
24442357
+
ADSL
chr22
40346500
40390463
+
AGAP1
chr2
235494043
236131800
+
AGPAT4
chr6
161129967
161274061
-
AGTPBP1
chr9
85546539
85742029
-
AHNAK
chr11
62433542
62556235
-
AIF1L
chr9
131096476
131123152
+
AL022238.4
chr22
40346529
40410054
+
AL133352.1
chr10
100505628
100529881
-
AL136454.1
chr1
192716132
192716653
+
AL139300.1
chr14
103562962
103685924
+
AL355315.1
chr10
97584374
97673910
+
ALDH7A1
chr5
126531200
126595362
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4426
chr1
192716333
192716349
+
hsa-miR-4485-3p
chr11
10508277
10508296
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
AC091564.7
chr11
6610883
6616594
-
AC104257.1
chr8
131308545
131317632
+
AC106864.1
chr4
112693047
112706810
-
AC239868.1
chr1
149861271
149862504
+
AC245033.4
chr15
82533175
82540008
-
AL031656.1
chr20
42685404
42688562
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.